TSXV/NURS (TSXV/NURS)

TSX Venture Exchange: TSXV/NURS · CAD

CA$3.48

+0.35 (+11.4%)· Recorded snapshot

Market cap	186.8M
Revenue (ttm)	78.4M
Net income (ttm)	6.7M
EPS (ttm)	CA$0.13
Shares out	53.7M
P/E (trailing)	27.0x
P/E (forward)	6.6x
Volume	80,186
Beta	0.63

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 78.4M
Net income (ttm): 6.7M
EPS (ttm): CA$0.13
P/E (trailing): 27.0x
P/E (forward): 6.6x
Market cap: 186.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E6.6

P25 n/aP50 n/aP75 n/a

Trailing P/E27

P25 n/aP50 n/aP75 n/a

ROE31.4

P25 n/aP50 n/aP75 n/a

ROIC16.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/NURS indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

CAD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-26
Enterprise value	CAD 175.6M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Health Information Services
Is primary listing	Yes
ISIN number	CA44877L1013
Last earnings date	2026-08-31
Last refreshed	2026-10-28
Last stock split date	2022-11-25
Last stock split type	Reverse
Market cap	CAD 186.8M
Next earnings date	2026-11-26
Price	CAD 3.48
Price currency	CAD
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	tsxv/NURS
Website	https://hydreight.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	24.13x
Earnings yield	3.7%
EV/Earnings	23.23x
EV/EBIT	22.11x
EV/EBITDA	20.4x
EV/Sales	2x
FCF / EV yield	-7.1%
FCF yield	-6.62%
Forward P/E	6.65x
Graham number	1.45985
Graham upside	-53.28%
P/B ratio	4.25x
P/E ratio	27.01x
P/S ratio	2.14x
Price / tangible book value	4.61x
Price/EBITDA ratio	21.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.04%
EBITDA margin	9.8%
Gross margin	20.51%
Operating margin	9.04%
Pretax margin	7.85%
Profit margin	8.59%
ROA	11.71%
ROA (5Y)	-49.09%
ROCE	14.57%
ROE	31.44%
ROIC	16.91%
SBC / revenue	0.02%
Tax / revenue	-0.74%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	390,272.73%
EPS growth (Q)	3,874.56%
EPS growth (QoQ)	1.03%
Gross profit growth	153.77%
Gross profit growth (Q)	181.7%
Gross profit growth 3Y	69.87%
Net income growth	478,192.12%
Net income growth (Q)	4,971.21%
Net income growth (QoQ)	-2.24%
Operating income growth (Q)	25,020.8%
Revenue growth	324.34%
Revenue growth (Q)	421.42%
Revenue growth (QoQ)	12.45%
Revenue growth 3Y	115.18%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -5,840
Depreciation and amortization	CAD 594,843
EBIT	CAD 7.1M
EBITDA	CAD 7.7M
EPS	CAD 0.13
FCF per share	CAD -0.21
Financing cash flow	CAD 26.2M
Free cash flow	CAD -11.1M
Free cash flow minus SBC	CAD -11.1M
Gross profit	CAD 16.1M
Income taxes	CAD -580,337
Investing cash flow	CAD -1.9M
Net borrowing	CAD 10.1M
Net cash flow	CAD 13.9M
Net income	CAD 6.7M
Operating cash flow minus SBC	CAD -11.1M
Operating income	CAD 7.1M
Revenue	CAD 78.4M
Stock-based compensation	CAD 15,905

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.2
Book value per share	CAD 0.74
Debt / EBITDA	1.14
Debt / equity	0.22
Interest coverage	4.61
Long-term assets	CAD 13.6M
Long-term liabilities	CAD 9.2M
Net cash (debt)	CAD 11.2M
Net cash / market cap	6.67%
Net cash growth	108.79%
Net debt / EBITDA	-1.46
Net debt / equity	-0.28
Piotroski F-Score	3
Property, plant and equipment	CAD 5,831
Shareholders' equity	CAD 39.5M
Tangible book value	CAD 36.4M
Tangible book value per share	CAD 0.68
Total assets	CAD 67M
Total cash	CAD 20M
Total debt	CAD 8.8M
Total liabilities	CAD 27.6M
WACC	8%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	2.07
Current assets	CAD 53.4M
Current liabilities	CAD 18.4M
Current ratio	2.91
Net working capital	CAD 15.1M
Quick ratio	2.13
Working capital	CAD 35.1M
Working capital turnover	4.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-23.42%
Shareholder yield	-23.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 3.85
1D price change	11.36%
1M price change	7.19%
1M total return	7.19%
1W price change	6.52%
1W total return	6.52%
1Y price change	-30%
1Y return CAGR	-30.02%
1Y total return	-30%
20-day SMA	CAD 3.38
200-day SMA	CAD 3.74
3M price change	-18.72%
3M total return	-18.72%
3Y price change	1,043.33%
3Y return CAGR	125.24%
3Y total return	1,043.33%
50-day SMA	CAD 3.48
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 5.59
52-week high date	2025-11-10
52-week low	CAD 2.38
52-week low date	2026-03-20
5Y price change	430.3%
5Y return CAGR	39.61%
5Y total return	430.3%
6M price change	-15.1%
6M total return	-15.1%
All-time high	CAD 5.59
All-time high date	2025-11-10
All-time low	CAD 0.20
All-time low date	2024-04-15
Average true range (ATR)	CAD 0.19
Average volume	41.2K
Beta (1Y)	0.14
Beta (2Y)	0.85
Beta (5Y)	0.63
Change from 52-week high	-37.75%
Change from 52-week low	46.22%
Change from all-time high	-38.64%
Change from all-time low	1,615%
Change from open	10.13%
Day's gap	1.12%
Dollar volume	CAD 279,047
High price	CAD 3.48
Low price	CAD 3.11
Monthly RSI	53.49
Open price	CAD 3.16
Position in 52-week range	100%
Previous close	CAD 3.13
Price vs 150-day SMA	-10.89%
Price vs 20-day SMA	1.63%
Price vs 200-day SMA	-8.22%
Price vs 50-day SMA	-1.44%
Relative volume	1.95
RSI	52.36
Sharpe ratio	-0.05
Sharpe ratio (3Y)	1.26
Sortino ratio	-0
Sortino ratio (3Y)	2.22
Volume	80.2K
Weekly RSI	45.67
YTD price change	-27.48%
YTD total return	-27.48%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27.3M
Shares change (QoQ)	-4.92%
Shares change (YoY)	23.42%
Shares held by insiders	1.88%
Shares held by institutions	1.44%
Shares outstanding	53.7M

Deeper analysis on TSXV/NURS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/NURS report

Is a complete TSXV/NURS research report available?

No complete published report is available for tsxv/NURS (TSXV/NURS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/NURS (TSXV/NURS)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/NURS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/NURS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/NURS

Frequently asked questions